Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
During the study period, the researchers tracked which of the 524,817 participants in the first group developed alcohol, cannabis, cocaine, nicotine, opioid or other substance use disorder
Is it safe to take GLP-1 drops while breastfeeding
Tirzepatide may also become an important pharmacological tool for the treatment of obesity if data from the SURMOUNT-1 trial are confirmed in other clinical studies (82)
Director, The Health Management Academy Key Takeaways GLP-1 drugs like Ozempic, Wegovy, Zepbound, and Mounjaro are now available across a wide cash-pay range, from roughly $150 to $450 per month, depending on drug, dose, and format